Robert Warner
Fort Worth, Tennessee
Mr. Warner joined Alcon in 1993 as a sales representative and quickly rose through the ranks. With a solid track record, in 1997 he transitioned to Pharmaceutical Marketing. His next move was to the new position of Global Director, Anti-Infectives, Combinations, and Otic products in 2000.
In 2004, he was promoted to Director, Global Pharmaceutical Marketing, responsible for the worldwide marketing of Alcon's $2 billion pharmaceutical portfolio. In 2006 he was appointed Vice President, Global Pharmaceutical Marketing and in 2007 received a promotion to Vice President/General Manager Pharmaceuticals.
As of April 2009, Mr. Warner was promoted to Vice President, U.S. Pharmaceutical Product, overseeing the U.S. Pharmaceutical organization with expanded corporate responsibilities. In February 2010 he accepted an executive assignment as corporate Vice President managing Alcon’s change from Nestle to Novartis majority share holder.


